biotech · Amyotrophic Lateral Sclerosis (ALS) · Amyotrophic Lateral Sclerosis · BCLI
BRAINSTORM CELL THERAPEUTICS
BRAINSTORM CELL THERAPEUTICS INC.
BRAINSTORM CELL THERAPEUTICS clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- NEW YORK, NY, USA
- Founded
- 2004
- Employees
- 30
- Programs
- 5
- Drugs
- 5
- Patents
- 8
BRAINSTORM CELL THERAPEUTICS projects
3 ClinicalTrials.gov programs sponsored by BRAINSTORM CELL THERAPEUTICS.
BRAINSTORM CELL THERAPEUTICS has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
MSC-NTF cells transplantation (IM)
BRAINSTORM CELL THERAPEUTICS INC.
Amyotrophic Lateral Sclerosis
1 trial -
MSC-NTF-002-HMO-CTIL
BRAINSTORM CELL THERAPEUTICS INC.
Amyotrophic Lateral Sclerosis
1 trial -
NurOwn (MSC-NTF cells)
BRAINSTORM CELL THERAPEUTICS INC.
Multiple Sclerosis, Chronic Progressive
1 trial
Frequently asked questions
How many clinical projects does BRAINSTORM CELL THERAPEUTICS have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.